Compare Acorda Therapeutics vs Banyan Biomarkers
Customers evaluate the quality of Acorda Therapeutics's products using the following success metrics.
Overview
Acorda Therapeutics is 29 yrs old and is based in United States.
Acorda Therapeutics is a biotechnology company with a focus on developing therapies for neurological disorders. The company's main offerings include treatments for conditions such as Parkinson’s disease, migraine, and multiple sclerosis, aimed at restoring neurological function and improving the lives of patients. Acorda primarily serves the biopharmaceutical industry. It was founded in 1995 and is based in Ardsley, New York.
Banyan Biomarkers is 11 yrs old and is based in United States.
Banyan Biomarkers is a company focused on the discovery, validation, and commercialization of biochemical markers in the healthcare sector. The company's main service is the development of a blood test that aids in the evaluation of concussions, potentially eliminating the need for CT scans in patients with suspected mild traumatic brain injury. The company primarily serves the healthcare industry, particularly in the area of traumatic brain injury diagnosis. It was founded in 2013 and is based in San Diego, California.
Demo Video
Leadership
Ron Cohen M D (Chief Executive Officer)
Ronald L Hayes (Founder, President)
Funding
Investors
Paycheck Protection Program, J.P. Morgan Chase & Co.
Paycheck Protection Program, bioMerieux
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Acorda Therapeutics has not claimed their profile.
Work for Acorda Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Acorda Therapeutics?
Claim your profile now.
Information not available because Banyan Biomarkers has not claimed their profile.
Work for Banyan Biomarkers? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Banyan Biomarkers?
Claim your profile now.